Navigation Links
Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market
Date:3/10/2008

Following Recovery From Withdrawal of Two COX-2 Inhibitors, the Chronic Pain Drug Market Will Regain Momentum, According to a New Report from

Decision Resources

WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that market penetration of drugs that have been newly labeled to treat neuropathic pain, including Pfizer's Lyrica and Eli Lilly's Cymbalta will be a key driver of growth in the chronic pain drug market through 2016.

The new Pharmacor report entitled Chronic Pain finds that, following recovery from the withdrawals in 2004 and 2005 of two COX-2 inhibitors, the chronic pain market will regain momentum over the next decade, with 5 to 6% annual growth in total sales in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

"In contrast to older established drugs like amitriptyline, new agents such as Lyrica and Cymbalta have the safety and efficacy data from large-scale clinical trials that will allow them to compete in this market," said Kate Hohenberg, director at Decision Resources. "Both of these drugs will achieve blockbuster status in the chronic pain drug market by 2011 and sales of Lyrica will exceed $2 billion by 2016."

The chronic pain drug market in Japan will be particularly robust from 2011 to 2016 as drugs that include Cymbalta, Lyrica and Endo's Lidoderm reach that market. Also driving growth in Japan will be Pfizer's Celebrex which reached the Japanese market in 2007. The report also finds that the continued use of opioid analgesics for chronic, non-cancer pain and the introduction of more-tolerable, safer opioid formulations in the next five years will drive opioid analgesic sales for chronic pain to more than $6 billion by 2016 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

About Chronic Pain

Key chron
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. First study examines newly-licensed RN work attitudes and intentions
2. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
3. Higher death rates in kidney patients with newly recognized disease
4. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
5. Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line
6. Corrected & Replaced - Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line
7. Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues
8. Striking shift seen among newly HIV-infected men regarding partners
9. Newly HIV-Infected Gay Men Select Other Infected Partners
10. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
11. New therapeutic options for newly diagnosed multiple myeloma patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-US...06 state prisoners and 1,538 federal prisoners wer...f Justice Statistics (BJS) in the Office of Justic...today. At yearend 2008, an estimated 5,672 inmates...down from 5,762 in 2007. In 2007, about 43 per 10,...
(Date:12/1/2009)...Could identify those who would benefit from liver ...UESDAY, Dec. 1 (HealthDay News) -- A CT scan of li...er may help predict overall survival after chemoth... (Avastin) to cytotoxic chemotherapy has been show...colorectal cancer and to produce better results in...
(Date:12/1/2009)... Practitioners of any med...anscription are breathing a sigh of relief this we...iPhone. The application, released over the holida...ranscribe voice recordings to do so quickly and se... (PRWEB) December 1, 2009 -- The...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /... and a global leader in the development and delive... for the medical, scientific and academic markets,...iversal Search, our first-to-market cross-platform...psychology lexicon, based on the American Psycholo...
(Date:12/1/2009)..., , FORT LAUDERDALE, Fla., Dec. 1 /PRNew...n of patient enrollment in the randomized clinical...ng Stent (Combo Stent). ,, A prospective, rando... E valuation of an ablu M inal sirolimus coat ...0 patients at up to 20 sites in Asia, Australia, E...
Breaking Medicine News(10 mins):Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4
...today that war veterans would have improved access...ollowing// the introduction of improved funding ar...eme for veterans’ health care. From 1 May, ...terms, this means that patients who see GPs for sp...
... is touted as a more eco-friendly fuel, than petro...d// use of ethanol could actually pose a threat to... not be that eco-friendly after all. The journey f... scientist Mark Z. Jacobson says that if every veh...
...will stay in the Los Arcos sanatorium for some mor...normal," his personal doctor Alfredo Cahe said. ...reated since Friday, said the patient is "clinical...toxic hepatitis due to his excessive drinking, whi...
...traying overall statistics of patients receiving t... AIDS has certainly reached many, though there is .... As per the recent figures, it is estimated...ith the figures of last year, there has been a rem...
... of the central nervous system that occurs primari...ata from a clinical trial at the// University of C...his cancerous tumor is always fatal. Findings from...attack the tumor cells, a function that is known m...
... of liver tissue samples ever acquired by a single... have embarked on a massive study// of one of the ...atty liver disease starts with the accumulation of...cirrhosis. If the damage becomes too great, a live...
Other Medicine News:Health News:Ethanol Could Be Damaging for Human Health, New Study Says 2Health News:Ethanol Could Be Damaging for Human Health, New Study Says 3Health News:UCSF Brain Tumor Vaccine Trial Shows Promising Results 2Health News:UCSF Brain Tumor Vaccine Trial Shows Promising Results 3Health News:Geisinger Launches Extensive Study on Obesity and Related Liver Problem 2
(Date:12/1/2009)...LL, N.J., Dec. 1 Former ...d and delighted when his radiotherapy treatment se...tes each day to less than five. Midway through hi...lley Urology Cancer Center acquired the region,s...om Varian Medical Systems (NYSE: VAR ), making i...
(Date:12/1/2009)...OKYO, Dec. 1 Galenea Corp. and Ots...urther extension of their research and development...n increases the collaboration term to seven years ...ately $90 million. The companies have been workin...covering and developing first-in-class therapies f...
(Date:12/1/2009)...c. 1 BioInformatics, LLC announces...tlook for Research Products in FY2010. The 8.2 b...Research program by the American Recovery and Rein...ovations, Challenge Grants, the Shared Instrumenta...ic and non-profit institutions, all of which will ...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3Cantel Medical Corp to Present at the UBS Global Life Sciences Conference 56751 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 4ABRISA Appoints Jim Veler as President CEO 13971 1ABRISA Appoints Jim Veler as President CEO 13971 2ABRISA Appoints Jim Veler as President CEO 13971 3
....--(BUSINESS WIRE)--Jun 20, 2007 - Materia, Inc., ... licensing of its,metathesis platform to Eisai Co.... for use in drug discovery and development.,The no...iscover,develop, and patent pharmaceutical compou...lysts and associated intellectual property., Metat...
...SINESS WIRE)--Jun 20, 2007 - Today, President Bush...n,s Commitment To,Research On Pluripotent Stem Cel...ngenuity and skill to pursue the potential benefit...cells that have the,potential to develop into near...thout endangering human life in the process. By,ex...
Other Medicine Technology:Materia Licenses Metathesis Catalyst Platform to Eisai 2Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 2Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 3
Cryotherm Neck Wrap
DuraKold Back wrap and Wrist/Elbow
Cryotherm Shoulder Wrap
DuraKold Shoulder Wrap
Medicine Products: